MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...
Monte Rosa Therapeutics (GLUE) advanced in premarket trading on Monday as the company entered into a supply agreement with Johnson & Johnson (JNJ) to evaluate its MRT-2359 in combination with ...
Colva: Fatorda police have registered a forgery case against three persons, including an advocate and a notary, in an attempt ...
Global media also looks at how Nitish Kumar shaped 'the Bihar of today', and the 'rare sense of optimism’ in Nepal after Balendra Shah’s ascent.